One of Bristol-Myers’s largest shareholders is opposing the company’s $74 billion deal to buy rival Celgene, becoming the latest investor to express its unhappiness with the transaction.
from WSJ.com: US Business https://ift.tt/2Vp3T2t
Subscribe to:
Post Comments (Atom)
My 3 years at Tesla were the best and worst of my life
Amanda Manley says her breaking point at Tesla was when she returned from maternity leave. Amanda Manley Amanda Manley was excited to g...
-
Before investing your own money into a small business idea, test it out with your target audience. Georgijevic/Getty Images Having a bu...
-
Krisanapong Detraphiphat/Getty Images; Jenny Change-Rodriguez/BI Illustration Goldman Sachs forecasts muted S&P 500 gains, with a ...
-
REUTERS/Lucas Jackson John Hussman warns of poor S&P 500 returns over the next 12 years. High valuations suggest potential underp...
No comments:
Post a Comment